SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-043298
Filing Date
2022-11-28
Accepted
2022-11-28 16:19:14
Documents
4
Period of Report
2022-12-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20005930x2_def14a.htm DEF 14A 490482
2 logo_statera.jpg GRAPHIC 59986
3 ny20005930x2_pc01x1.jpg GRAPHIC 681894
4 ny20005930x2_pc02x1.jpg GRAPHIC 561591
  Complete submission text file 0001140361-22-043298.txt   2286026
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32954 | Film No.: 221425721
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences